Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease

Diabetes Care - United States
doi 10.2337/dc16-0173
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Circulating Endothelial Cells and Cardiovascular Risk in Chronic Kidney Disease and Hemodialysis Patients

Journal of Medical Science And clinical Research
2016English

Nonglycemic Effects of Incretins in Patients With Long-Term Type 1 Diabetes Mellitus and Chronic Kidney Disease

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Inсretin-Based Therapy in Patients With Type 2 Diabetes and Chronic Kidney Disease

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Risk Factors for Kidney Disease in Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Metformin in Patients With Type 2 Diabetes and Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy